PRODUCTS
MEROFLEX 2:1
Meroflex 2:1
Cannabis sativa L. extract / Oral drops solution.
Composition per 100 mL: Diluted extract containing Cannabidiol (CBD): 2.2 g and Tetrahydrocannabinol (THC): 0.9 g
Oleous carrier q.s. 100 mL.
INDICATIONS
The use of this product, dosage indications and monitoring should be carried out ONLY under medical prescription.
CONTRAINDICATIONS
– Psychotic disorders.
– Patients with problems
psychological.
– Heart problems: cardiac arrhythmias, coronary insufficiency
or patients who have had angina pectoris or a heart attack.
– People who have to use machinery or have to drive: in this case, it is recommended, if the product has been consumed, to wait at least four hours before resuming activities.
INTERACTIONS
• Selective serotonin uptake inhibitor antidepressants: THC may increase the effect of fluoxetine.
• Tricyclic antidepressants: THC can increase the side effects of amitriptyline, which include tachycardia, hypertension and amitriptyline, including tachycardia, hypertension and sedation.
• Nonsteroidal anti-inflammatory drugs: Indomethacin and acetylsalicylic acid reduce the effects of THC.
• Barbiturates: They increase the depressant effects of THC and also increase the tachycardia caused by THC use.
• Benzodiazepines: can increase the depression of the nervous system and also the respiratory system.
• Beta-blockers: Reduce the tachycardia associated with THC.
• Ethanol (alcohol): may increase nervous system impairment.
• Opiates: increase sedation and analgesia.
• Theophylline: Cannabinoids increase theophylline catabolism.
• Anticholinergics: Atropine and scopolamine may increase the tachycardia produced by THC.
• Disulfiram: THC interacts with disulfiram, producing a very unpleasant reaction for the patient.
• If you are taking any medication, consult your doctor about the possibility of using this product.
SIDE EFFECTS
After consuming the product, the person may have a feeling of euphoria which gradually changes to a sense of euphoria that gradually changes to a feeling of contentment, calm and tranquillity.
Other effects may include: relaxation, fits of laughter, appetite, heightened sensitivity to music and colours, change of sense of space and time, and peripheral peripheral to music and colours, change of sense of space and time and sluggishness.
A lack of reaction may also occur, especially during the first hours after use. The first four hours after ingestion should be taken into account.
The changed perception can lead to feelings of fear, panic and confusion.
Daily use may affect memory and ability to concentrate.
Cases of restlessness and insomnia have been reported.
It can also lead to a psychotic reaction, which can be recognised by hallucinations. Other side effects are: tachycardia, orthostatic hypotension (when standing), headache, dizziness, feeling hot and cold in the feet and hands at the same time, red eyes, numb muscles, dry mouth.
In case of PREGNANCY and BREASTFEEDING
Use is not recommended during pregnancy and breastfeeding, as cannabinoid compounds can reach the foetus and can also be excreted in breast milk.
CONSERVATION
Keep out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the pack. Store the product in an upright position at a temperature below 30 °C. Do not use Meroflex after opening for more than 45 days.
PRESENTATION
lue glass dropper bottle of 30 mL capacity. Composition per 100 mL: Diluted extract containing Cannabidiol (CBD): 2.2 g and Delta-9 tetrahydrocannabinol (THC): 0.9 g
Oily vehicle q.s. 100 mL.
Manufacturer
BUREY S.A.
MSP Registration
Camino Saravia y Ruta 8, Parque Tecnológico
Technological and Scientific Park of Pando
Canelones, Uruguay.
Buy your product here.
Fill in your data to follow up on your service.
GrüneLabs is a global Phytopharmaceutical company with operations in Uruguay, and Portugal.
+598 2291 4543
- Uruguay
Departamento de Canelones
- Portugal
Parque Industrial Gardunha Sul
6005-300 | Soalheira
Castelo Branco